English | Español
Patient Daily | Nov 25, 2025

Bliksem Health founder Rojas on 340B reform: '340B has been weaponised by the largest entities and must be cut off'
Patient Daily | Nov 21, 2025

Texas voters approve $3 billion funding plan for new Dementia Prevention institute
Patient Daily | Nov 21, 2025

Oral Health Foundation highlights lasting impact of mouth cancer on diet
Patient Daily | Nov 21, 2025

Baylor researchers find protein may help clear Alzheimer’s-related plaques
Patient Daily | Nov 20, 2025

Oral Health Foundation reports high out-of-pocket costs for UK mouth cancer patients
Patient Daily | Nov 20, 2025

Early introduction linked to sharp drop in childhood peanut allergies
Patient Daily | Nov 20, 2025

UTHealth Houston researcher leads trial showing benefits of new oral GLP-1 pill for diabetes
Patient Daily | Nov 20, 2025

Baylor College receives over $15 million from CPRIT for cancer research projects

Trending
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+ Regulatory
Patient Daily | Apr 9, 2026

Reason Foundation commentator on vaccine liability: 'Exposing vaccine makers to the machinations of trial lawyers will stymie the development of innovative vaccines'
+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'